Inovio Pharmaceuticals, Inc. (INO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.11-0.03 (-0.35%)
As of 10:41AM EDT. Market open.
| Previous close | 7.13 |
| Open | 7.06 |
| Bid | 7.08 x 1200 |
| Ask | 7.09 x 800 |
| Day's range | 6.97 - 7.11 |
| 52-week range | 5.81 - 19.00 |
| Volume | 600,095 |
| Avg. volume | 4,170,258 |
| Market cap | 1.489B |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.08 |
| Earnings date | 10 May 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.33 |
- Simply Wall St.
Breakeven On The Horizon For Inovio Pharmaceuticals, Inc. (NASDAQ:INO)
Inovio Pharmaceuticals, Inc. ( NASDAQ:INO ) is possibly approaching a major achievement in its business, so we would...
- Motley Fool
4 Growth Stocks With 187% to 434% Upside, According to Wall Street
Based on analysts' loftiest price targets, these companies could nearly triple or potentially quintuple investors' money over the next year.
- Motley Fool
Is This The Turning Point for Inovio?
It seems such a long time ago that Inovio Pharmaceuticals (NASDAQ: INO) was considered one of the leaders in the hunt for a COVID-19 vaccine -- but the biotech was left in the dust by peers and many investors have given up on the stock. In the past 12 months, shares of Inovio are down 45% even as the broader market took off. Let's see whether the company is finally ready to turn things around.
© 2021 Verizon Media. All rights reserved.
